2. Academic Validation
  3. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression

EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression

  • Oncogene. 2019 Jan;38(5):747-764. doi: 10.1038/s41388-018-0473-z.
Lei Liu 1 2,  Yi Yang 3 4,  Shihua Liu 1 2,  Tianyu Tao 1 2,  Junchao Cai 1 2,  Jueheng Wu 1 2,  Hongyu Guan 5,  Xun Zhu 1 6,  Zhenjian He 1 7,  Jun Li 1 8,  Erwei Song 9,  Musheng Zeng 10,  Mengfeng Li 11 12
Affiliations

Affiliations

  • 1 Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China.
  • 2 Department of Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • 3 Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China. yangyi23@mail.sysu.edu.cn.
  • 4 Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China. yangyi23@mail.sysu.edu.cn.
  • 5 Department of Endocrinology and Diabetes Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
  • 6 Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, Guangzhou, Guangdong, China.
  • 7 School of Public-Health, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • 8 Department of Biochemistry, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • 9 Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • 10 State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
  • 11 Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou, Guangdong, China. limf@mail.sysu.edu.cn.
  • 12 Department of Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China. limf@mail.sysu.edu.cn.
PMID: 30177836 DOI: 10.1038/s41388-018-0473-z
Abstract

Aberrant activation of EGFR represents a common event in non-small cell lung carcinoma (NSCLC) and activates various downstream signaling pathways. While EGFR activation of β-catenin signaling was previously reported, the mediating mechanism remains unclear. Our current study found that EGFR activation in NSCLC cells releases SHC-binging protein 1 (SHCBP1) from SHC adaptor protein 1 (SHC1), which subsequently translocates into the nucleus and directly promotes the transactivating activity of β-catenin, consequently resulting in development of NSCLC cell stemness and malignant progression. Furthermore, SHCBP1 promotes β-catenin activity through enhancing the CBP/β-catenin interaction, and most interestingly, a candidate drug that blocks the CBP/β-catenin binding effectively abrogates the aforementioned biological effects of SHCBP1. Clinically, SHCBP1 level in NSCLC tumors was found to inversely correlate with patient survival. Together, our study establishes a novel convergence between EGFR and β-catenin pathways and highlights a potential significance of SHCBP1 as a prognostic biomarker and a therapeutic target.

Figures
Products